| 4301 |
Cord Tissue |
Allogeneic – Unrelated |
Other Specific Disorders Of The Central Nervous System; Cornelia De Lange Syndrome |
Neurology |
2020 |
Experimental Therapy |
Poland |
4,4 |
| 4302 |
Cord Tissue |
Allogeneic – Unrelated |
Other Specific Disorders Of The Central Nervous System; Hypoxia-Ischemic Encephalopathy |
Neurology |
2020 |
Experimental Therapy |
Poland |
4,3 |
| 4303 |
Cord Tissue |
Allogeneic – Unrelated |
Other Specific Disorders Of The Central Nervous System; Lissencephaly |
Neurology |
2020 |
Experimental Therapy |
Poland |
6,4 |
| 4304 |
Cord Tissue |
Allogeneic – Unrelated |
Other Sphingolipidoses; Krabbe's Leukodystrophy |
Neurology |
2020 |
Experimental Therapy |
Poland |
4 |
| 4305 |
Cord Tissue |
Allogeneic – Unrelated |
Other Spinal Muscular Atrophy And Related Syndromes; Bulbar Palsy |
Neurology |
2020 |
Experimental Therapy |
Poland |
no data |
| 4306 |
Cord Tissue |
Allogeneic – Unrelated |
Polyneuropathy |
Neurology |
2020 |
Experimental Therapy |
Poland |
43,11 |
| 4307 |
Cord Tissue |
Allogeneic – Unrelated |
Sclerosis Multiplex |
Neurology |
2020 |
Experimental Therapy |
Poland |
33,7 |
| 4308 |
Cord Tissue |
Allogeneic – Unrelated |
Sclerosis Multiplex |
Neurology |
2020 |
Experimental Therapy |
Poland |
61,5 |
| 4309 |
Cord Tissue |
Allogeneic – Unrelated |
Soft Tissue Diseases Related To Use, Overload And Pressure |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
59,6 |
| 4310 |
Cord Tissue |
Allogeneic – Unrelated |
Spina Bifida |
Neurology |
2020 |
Experimental Therapy |
Poland |
11 months |
| 4311 |
Cord Tissue |
Allogeneic – Unrelated |
Spina Bifida |
Neurology |
2020 |
Experimental Therapy |
Poland |
1,3 |
| 4312 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2020 |
Experimental Therapy |
Poland |
33,2 |
| 4313 |
Cord Tissue |
Allogeneic – Unrelated |
Spinocerebellar Ataxia |
Neurology |
2020 |
Experimental Therapy |
Poland |
37,11 |
| 4314 |
Cord Tissue |
Allogeneic – Unrelated |
State After Encephalitis |
Neurology |
2020 |
Experimental Therapy |
Poland |
3,8 |
| 4315 |
Cord Tissue |
Allogeneic – Unrelated |
Tendon Injury |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
29 |
| 4316 |
Cord Tissue |
Allogeneic – Unrelated |
Transplantation Failure; Coexisting Viral Infections |
Hematology |
2020 |
Experimental Therapy |
Poland |
13,1 |
| 4317 |
Cord Tissue |
Allogeneic |
Cerebral Palsy – condition after a sudden stoke |
Neurology |
2020 |
Experimental Therapy |
Slovakia |
63 |
| 4318 |
Cord Blood |
Autologous |
Autism |
Neurology |
2020 |
Experimental Therapy |
Poland |
no data |
| 4319 |
Cord Blood |
Autologous |
Autism |
Neurology |
2020 |
Experimental Therapy |
Germany |
9 |
| 4320 |
Cord Blood |
Autologous |
Autism |
Neurology |
2020 |
Experimental Therapy |
Germany |
5 |
| 4321 |
Cord Blood |
Autologous |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
UK |
5 |
| 4322 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2020 |
Experimental Therapy |
Poland |
2,2 |
| 4323 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2020 |
Experimental Therapy |
Poland |
2,9 |
| 4324 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2020 |
Experimental Therapy |
Poland |
2,4 |
| 4325 |
Cord Blood |
Allogeneic – Related |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
no data |
| 4326 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Turkey |
3,4 |
| 4327 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Turkey |
3,4 |
| 4328 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Turkey |
4,4 |
| 4329 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Turkey |
4,4 |
| 4330 |
Cord Blood |
Allogeneic |
Cerebral Palsy – condition after a sudden stoke |
Neurology |
2020 |
Experimental Therapy |
Slovakia |
63 |
| 4331 |
Cord Blood |
Autologous |
Drowning – Persistent Vegetative State, Decortication |
Neurology |
2020 |
Experimental Therapy |
Czechia |
2 |
| 4332 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia – Relapse |
Hematology |
2020 |
Standard Therapy |
Germany |
57 |
| 4333 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
69 |
| 4334 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
48 |
| 4335 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
64 |
| 4336 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
72 |
| 4337 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
59 |
| 4338 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
38 |
| 4339 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4340 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Germany |
76 |
| 4341 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2020 |
Standard Therapy |
Germany |
61 |
| 4342 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2020 |
Standard Therapy |
Germany |
68 |
| 4343 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4344 |
Bone Marrow Family |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
35 |
| 4345 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
71 |
| 4346 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
31 |
| 4347 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
62 |
| 4348 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
59 |
| 4349 |
Bone Marrow Family |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
67 |
| 4350 |
Bone Marrow Family |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4351 |
Bone Marrow Family |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
70 |
| 4352 |
Bone Marrow Family |
Allogeneic |
T-Cell Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Germany |
24 |
| 4353 |
Bone Marrow (Apheresismily donor) |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
68 |
| 4354 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
14 |
| 4355 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
1 |
| 4356 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
52 |
| 4357 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
66 |
| 4358 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
4 |
| 4359 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
15 |
| 4360 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
5 |
| 4361 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
3 |
| 4362 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
62 |
| 4363 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
47 |
| 4364 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
1 |
| 4365 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
16 |
| 4366 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
43 |
| 4367 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
9 |
| 4368 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
10 |
| 4369 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
27 |
| 4370 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
23 |
| 4371 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2020 |
Standard Therapy |
Poland |
6 |
| 4372 |
Bone Marrow |
Allogeneic |
Congenital Neutropenia |
Hematology |
2020 |
Standard Therapy |
Poland |
2 |
| 4373 |
Bone Marrow |
Allogeneic |
Familial Hemophagocytic Lymphohistiocytosis Type 2 |
Hematology |
2020 |
Standard Therapy |
Poland |
8 |
| 4374 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
11 |
| 4375 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
6 |
| 4376 |
Bone Marrow |
Allogeneic |
Immune Deficiency; Neutropenia |
Hematology |
2020 |
Standard Therapy |
Poland |
4 |
| 4377 |
Bone Marrow |
Allogeneic |
Metachromatic Leukodystrophy |
Hematology |
2020 |
Standard Therapy |
Poland |
6 |
| 4378 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type I |
Hematology |
2020 |
Standard Therapy |
Poland |
2 |
| 4379 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type Ii |
Hematology |
2020 |
Standard Therapy |
Poland |
1 |
| 4380 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
52 |
| 4381 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
54 |
| 4382 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
3 |
| 4383 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
28 |
| 4384 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2020 |
Standard Therapy |
Poland |
1 |
| 4385 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2020 |
Standard Therapy |
Poland |
10 |
| 4386 |
Bone Marrow |
Allogeneic |
Osteopetrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
1 |
| 4387 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency With Severe Mds Associated |
Hematology |
2020 |
Standard Therapy |
Poland |
14 |
| 4388 |
Bone Marrow |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4389 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
5 |
| 4390 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
57 |
| 4391 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
27 |
| 4392 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
43 |
| 4393 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
10 |
| 4394 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
34 |
| 4395 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
11 |
| 4396 |
Bone Marrow |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
12 |
| 4397 |
Bone Marrow |
Allogeneic |
X-Linked Chronic Granulomatous Disease |
Hematology |
2020 |
Standard Therapy |
Poland |
5 |
| 4398 |
Bone Marrow |
Allogeneic |
Β – Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Poland |
13 |
| 4399 |
Bone Marrow |
Allogeneic |
Β – Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Poland |
17 |
| 4400 |
Bone Marrow |
Allogeneic |
Β – Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Poland |
6 |